{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:45:05Z","timestamp":1790707505607,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP1143674"],"award-info":[{"award-number":["APP1143674"]}]},{"name":"National Health and Medical Research Council of Australia","award":["APP1062721"],"award-info":[{"award-number":["APP1062721"]}]},{"name":"National Health and Medical Research Council of Australia","award":["APP1006017"],"award-info":[{"award-number":["APP1006017"]}]},{"name":"National Health and Medical Research Council of Australia","award":["APP1079467"],"award-info":[{"award-number":["APP1079467"]}]},{"name":"National Health and Medical Research Council of Australia","award":["APP1079492"],"award-info":[{"award-number":["APP1079492"]}]},{"name":"National Health and Medical Research Council of Australia","award":["APP1041766"],"award-info":[{"award-number":["APP1041766"]}]},{"name":"European Research Council InflammAct","award":["616777"],"award-info":[{"award-number":["616777"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/cvr\/cvy252","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T06:53:50Z","timestamp":1540277630000},"page":"776-787","source":"Crossref","is-referenced-by-count":268,"title":["Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension"],"prefix":"10.1093","volume":"115","author":[{"given":"Shalini M","family":"Krishnan","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong H","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke M","family":"Huuskes","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota M","family":"Ferens","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narbada","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Diep","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M","family":"Kett","sequence":"additional","affiliation":[{"name":"Department of Physiology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrishan S","family":"Samuel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K","family":"Kemp-Harper","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avril A B","family":"Robertson","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A","family":"Cooper","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Peter","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eicke","family":"Latz","sequence":"additional","affiliation":[{"name":"Institute of Innate Immunity, University Hospital Bonn, University of Bonn, Bonn, Germany"},{"name":"Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S","family":"Mansell","sequence":"additional","affiliation":[{"name":"Hudson Institute of Medical Research, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G","family":"Sobey","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R","family":"Drummond","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Vinh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Monash University, Clayton, Victoria, Australia"},{"name":"Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne Campus, Bundoora, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrneph.2012.191","article-title":"The role of the kidney in regulating arterial blood pressure","volume":"8","author":"Wadei","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B2","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1113\/jphysiol.2014.271676","article-title":"Pressure natriuresis and the renal control of arterial blood pressure","volume":"592","author":"Ivy","year":"2014","journal-title":"J Physiol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10354-008-0559-2","article-title":"An update on the relationship between the kidney, salt and hypertension","volume":"158","author":"Mayer","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1573402111666150530204136","article-title":"Mechanisms of salt-sensitive hypertension","volume":"11","author":"Luzardo","year":"2015","journal-title":"Curr Hypertens Rev"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B5","doi-asserted-by":"crossref","first-page":"R1817","DOI":"10.1152\/ajpregu.00153.2006","article-title":"Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats","volume":"291","author":"Gu","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1440-1681.2011.05482.x","article-title":"Renal inflammation, autoimmunity and salt-sensitive hypertension","volume":"39","author":"Rodr\u00edguez-Iturbe","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bph.13230","article-title":"Inflammasome activity is essential for one kidney\/deoxycorticosterone acetate\/salt-induced hypertension in mice","volume":"173","author":"Krishnan","year":"2016","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","article-title":"The inflammasomes: mechanisms of activation and function","volume":"22","author":"Latz","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B10","doi-asserted-by":"crossref","first-page":"e29004.","DOI":"10.1371\/journal.pone.0029004","article-title":"Pivotal role of toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis","volume":"6","author":"Correa-Costa","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); Genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B16","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1096\/fj.15-271734","article-title":"Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice","volume":"29","author":"Kadoya","year":"2015","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B17","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1210\/en.2015-1408","article-title":"NLRP3 deficiency improves angiotensin II-induced hypertension but not fetal growth restriction during pregnancy","volume":"156","author":"Shirasuna","year":"2015","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fimmu.2017.00782","article-title":"Inhibition of the NOD-like receptor protein 3 inflammasome is protective in juvenile influenza a virus infection","volume":"8","author":"Coates","year":"2017","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice\u2014brief report","volume":"37","author":"Heijden","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2016.12.015","article-title":"Anakinra reduces blood pressure and renal fibrosis in one kidney\/DOCA\/salt-induced hypertension","volume":"116","author":"Ling","year":"2017","journal-title":"Pharmacol Res"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B23","doi-asserted-by":"crossref","first-page":"H9069","DOI":"10.1152\/ajpheart.00821.2014","article-title":"M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss and elevated blood pressure","volume":"309","author":"Moore","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B24","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-\u03b3 production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cvr\/cvt258","article-title":"Inhibition of toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation","volume":"101","author":"Wang","year":"2014","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2016.05.016","article-title":"Cardiac macrophages adopt profibrotic\/M2 phenotype in infarcted hearts: role of urokinase plasminogen activator","volume":"108","author":"Carlson","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biocel.2010.10.013","article-title":"TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P","volume":"43","author":"Murray","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/annrheumdis-2016-210189","article-title":"Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages","volume":"76","author":"Maier","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B29","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.1201959","article-title":"Inflammasome-independent NLRP3 augments TGF-signaling in kidney epithelium","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10735-017-9720-9","article-title":"Uric acid activates NRLP3 inflammasome in an in-vivo model of epithelial to mesenchymal transition in the kidney","volume":"48","author":"Romero","year":"2017","journal-title":"J Mol Histol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","article-title":"IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells","volume":"12","author":"Tominaga","year":"2000","journal-title":"Int Immunol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/HYPERTENSIONAHA.114.04975","article-title":"Renal transporter activation during angiotensin-II hypertension is blunted in interferon-\u03b3-\/-and interleukin-17A-\/-mice","volume":"65","author":"Kamat","year":"2015","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B35","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/HYPERTENSIONAHA.114.04147","article-title":"Oligoclonal CD8+ T cells play a critical role in the development of hypertension","volume":"64","author":"Trott","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B37","doi-asserted-by":"crossref","first-page":"28715.","DOI":"10.1038\/srep28715","article-title":"CXCL16 deficiency attenuates renal injury and fibrosis in salt-sensitive hypertension","volume":"6","author":"Liang","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/jpet.105.088435","article-title":"Increased superoxide anion production by interleukin-1beta impairs nitric oxide-mediated relaxation in resistance arteries","volume":"316","author":"Jimenez-Altayo","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B39","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/CIRCULATIONAHA.116.024369","article-title":"NLRP3 inflammasome mediates aldosterone-induced vascular damage","volume":"134","author":"Bruder-Nascimento","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B40","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1681\/ASN.V94614","article-title":"Role of IL-1 in renal ischemic reperfusion injury","volume":"9","author":"Haq","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B42","doi-asserted-by":"crossref","first-page":"e47299.","DOI":"10.1371\/journal.pone.0047299","article-title":"Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney","volume":"7","author":"Chung","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B43","doi-asserted-by":"crossref","first-page":"F75","DOI":"10.1152\/ajprenal.00117.2013","article-title":"Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway","volume":"306","author":"Yang","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B44","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1038\/ncomms7931","article-title":"Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation","volume":"6","author":"Ip","year":"2015","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B45","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ajh\/hpv031","article-title":"The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies","volume":"28","author":"Dahal","year":"2015","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019040308501055100_cvy252-B46","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/115\/4\/776\/28268184\/cvy252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:12:09Z","timestamp":1693987929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/115\/4\/776\/5144200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,24]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvy252","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2018,10,24]]}}}